Evolving Considerations in the Treatment of Metastatic Head and Neck Squamous Cell Carcinoma: A Closer Look at the Role of Immunotherapy.

Immunotherapy is a dramatic advance in the treatment of metastatic head and neck squamous cell carcinoma. Checkpoint inhibitors are improving survival in patients with late-stage disease and are moving into earlier lines of therapy.